AstraZeneca (Group)

http://www.astrazeneca.com

Twitter: @AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For nearly three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and over the past five years, has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. *

	Start	1999-04-05 merged
	Predecessor	Zeneca (Group)
	Industry	pharmaceutical
	Person	Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
	Person 2	Dunoyer, Marc (AstraZeneca 201311– CFO joined 201303 as EVP Global Portfolio + Product Strategy before GSK)

	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	15 Stanhope Gate
	City	W1K 1LN London
	Tel	+44-20-7304-5000
		Address record changed: 2018-07-24

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	22,465,000,000 (revenue, total, consolidated (2017) 2017-12-31)
	Profit	2,868,000,000 (2017-12-31)
	Cash	3,324,000,000 (2017-12-31)

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2019-12-31

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

AstraZeneca (Group)

More documents for AstraZeneca (Group)